Literature DB >> 1426254

Carbohydrate binding specificity of the Tn-antigen binding lectin from Vicia villosa seeds (VVLB4).

K D Puri1, B Gopalakrishnan, A Surolia.   

Abstract

2-Dansylamino-2-deoxy-D-galactose (GalNDns) is a useful fluorescent probe to study the interaction of non-fluorescent sugars with the B4 lectin from Vicia villosa seeds (VVLB4). Binding of the lectin to GalNDns leads to a 5.2-fold increase in Dansyl fluorescence with a concomitant 10 nm blue shift in its emission maximum. The strong binding of GalNDns (Ka = 7.33 x 10(4) M-1 at 20 degrees C) is due to a favourable entropic contribution to the association process. Among the other sugars studied, GalNAc alpha 1-O-Ser followed by Me alpha GalNAc are the best ligands. 2-Deoxygalactose, galactosamine and galactose are 2013, 469 and 130 times weaker ligands, respectively, as compared to GalNAc, whereas GalNDns is about 2.44 times more potent than GalNAc, indicating that substitutions at the C-2 position of GalNAc have a considerable influence on the binding affinities. Equatorial orientation of the hydroxyl group at C-3 and axial orientation at C-4 as in galactose are important for the interaction with VVLB4. The C-6 hydroxyl group is not indispensable. The binding site of the lectin is directed exclusively towards monosaccharides alone. Interestingly enough, despite its preference for Me alpha GalNAc over Me beta GalNAc, in oligosaccharides, the lectin prefers terminal beta-linked GalNAc as compared to the alpha-linked one.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426254     DOI: 10.1016/0014-5793(92)80937-c

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  A Tn antigen binding lectin from Myrsine coriacea displays toxicity in human cancer cell lines.

Authors:  Andrea Medeiros; Nora Berois; Marcelo Incerti; Sylvie Bay; Laura Franco Fraguas; Eduardo Osinaga
Journal:  J Nat Med       Date:  2012-05-30       Impact factor: 2.343

2.  Sialylation of Thomsen-Friedenreich antigen is a noninvasive blood-based biomarker for GNE myopathy.

Authors:  Petcharat Leoyklang; May Christine Malicdan; Tal Yardeni; Frank Celeste; Carla Ciccone; Xueli Li; Rong Jiang; William A Gahl; Nuria Carrillo-Carrasco; Miao He; Marjan Huizing
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

3.  Galnt3 deficiency disrupts acrosome formation and leads to oligoasthenoteratozoospermia.

Authors:  Toshihiro Miyazaki; Masako Mori; Carolina A Yoshida; Chizuru Ito; Kenji Yamatoya; Takeshi Moriishi; Yosuke Kawai; Hisato Komori; Tetsuya Kawane; Shin-ichi Izumi; Kiyotaka Toshimori; Toshihisa Komori
Journal:  Histochem Cell Biol       Date:  2012-09-28       Impact factor: 4.304

4.  An array-based method to identify multivalent inhibitors.

Authors:  Yalong Zhang; Qian Li; Luis G Rodriguez; Jeffrey C Gildersleeve
Journal:  J Am Chem Soc       Date:  2010-07-21       Impact factor: 15.419

5.  GalNAc-Tyrosine Is a Ligand of Plant Lectins, Antibodies, and Human and Murine Macrophage Galactose-Type Lectins.

Authors:  Ruslan Gibadullin; David Wayne Farnsworth; Joseph J Barchi; Jeffrey C Gildersleeve
Journal:  ACS Chem Biol       Date:  2017-07-14       Impact factor: 5.100

6.  The Gne M712T mouse as a model for human glomerulopathy.

Authors:  Sravan Kakani; Tal Yardeni; Justin Poling; Carla Ciccone; Terren Niethamer; Enriko D Klootwijk; Irini Manoli; Daniel Darvish; Shelley Hoogstraten-Miller; Patricia Zerfas; E Tian; Kelly G Ten Hagen; Jeffrey B Kopp; William A Gahl; Marjan Huizing
Journal:  Am J Pathol       Date:  2012-02-07       Impact factor: 4.307

7.  Presynaptic secretion of mind-the-gap organizes the synaptic extracellular matrix-integrin interface and postsynaptic environments.

Authors:  Emma Rushton; Jeffrey Rohrbough; Kendal Broadie
Journal:  Dev Dyn       Date:  2009-03       Impact factor: 3.780

8.  Aberrant development of neuromuscular junctions in glycosylation-defective Large(myd) mice.

Authors:  Ruth Herbst; Thomas Iskratsch; Ewald Unger; Reginald E Bittner
Journal:  Neuromuscul Disord       Date:  2009-04-05       Impact factor: 4.296

9.  Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy.

Authors:  Terren K Niethamer; Tal Yardeni; Petcharat Leoyklang; Carla Ciccone; Adrian Astiz-Martinez; Katherine Jacobs; Heidi M Dorward; Patricia M Zerfas; William A Gahl; Marjan Huizing
Journal:  Mol Genet Metab       Date:  2012-10-18       Impact factor: 4.797

10.  Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies.

Authors:  Oyindasola Oyelaran; Qian Li; David Farnsworth; Jeffrey C Gildersleeve
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.